An autoantigen profile from Jurkat T-Lymphoblasts provides a molecular guide for investigating autoimmune sequelae of COVID-19
Julia Y. Wang
A * , Wei Zhang B , Michael W. Roehrl A , Victor B. Roehrl A and Michael H. Roehrl C D *
A Curandis, Boston, MA, USA.
B Department of Gastroenterology, Affiliated Hospital of Guizhou Medical University, Guizhou, China.
C Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
D Harvard Medical School, Boston, MA, USA.
Handling Editor: John Wade
Australian Journal of Chemistry 76(8) 508-524 https://doi.org/10.1071/CH22268
Submitted: 20 December 2022 Accepted: 6 June 2023 Published: 20 July 2023
Abstract
In order to understand autoimmune phenomena contributing to the pathophysiology of COVID-19 and post-COVID syndrome, we have been profiling autoantigens (autoAgs) from various cell types. Although cells share numerous autoAgs, each cell type gives rise to unique COVID-altered autoAg candidates, which may explain the wide range of symptoms experienced by patients with autoimmune sequelae of SARS-CoV-2 infection. Based on the unifying property of affinity between autoAgs and the glycosaminoglycan dermatan sulfate (DS), this paper reports 140 candidate autoAgs identified from proteome extracts of human Jurkat T-cells, of which at least 105 (75%) are known targets of autoantibodies. Comparison with currently available multi-omic COVID-19 data shows that 125 (89%) DS-affinity proteins are altered at protein and/or RNA levels in SARS-CoV-2-infected cells or patients, with at least 94 being known autoAgs in a wide spectrum of autoimmune diseases and cancer. Protein alterations by ubiquitination and phosphorylation during the viral infection are major contributors of autoAgs. The autoAg protein network is significantly associated with cellular response to stress, apoptosis, RNA metabolism, mRNA processing and translation, protein folding and processing, chromosome organization, cell cycle, and muscle contraction. The autoAgs include clusters of histones, CCT/TriC chaperonin, DNA replication licensing factors, proteasome and ribosome proteins, heat shock proteins, serine/arginine-rich splicing factors, 14-3-3 proteins, and cytoskeletal proteins. AutoAgs, such as LCP1 and NACA, that are altered in the T cells of COVID patients may provide insight into T-cell responses to viral infection and merit further study. The autoantigen-ome from this study contributes to a comprehensive molecular map for investigating acute, subacute, and chronic autoimmune disorders caused by SARS-CoV-2.
Keywords: autoantibodies, autoantigens, autoimmunity, COVID-19, long COVID, dermatan sulfate, SARS-Cov-2, T cell immunity.
References
1 Wang JY, Zhang W, Roehrl MW, Roehrl VB, Roehrl MH. An Autoantigen Atlas from Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19. Front Immunol 2022; 13: 831849.
| Crossref | Google Scholar | PubMed |
2 Wang JY, Zhang W, Roehrl MW, Roehrl VB, Roehrl MH. An Autoantigen Profile of Human A549 Lung Cells Reveals Viral and Host Etiologic Molecular Attributes of Autoimmunity in COVID-19. J Autoimmun 2021; 120: 102644.
| Crossref | Google Scholar | PubMed |
3 Wang JY, Zhang W, Roehrl VB, Roehrl MW, Roehrl MH. An Autoantigen-ome from HS-Sultan B-Lymphoblasts Offers a Molecular Map for Investigating Autoimmune Sequelae of COVID-19. Aust J Chem 2023;
| Crossref | Google Scholar |
4 Wang JY, Lee J, Yan M, Rho J-h, Roehrl MHA. Dermatan sulfate interacts with dead cells and regulates CD5+ B-cell fate: implications for a key role in autoimmunity. Am J Pathol 2011; 178(5): 2168-76.
| Crossref | Google Scholar |
5 Rho J-h, Zhang W, Murali M, Roehrl MHA, Wang JY. Human proteins with affinity for dermatan sulfate have the propensity to become autoantigens. Am J Pathol 2011; 178(5): 2177-90.
| Crossref | Google Scholar |
6 Lee J, Rho J-h, Roehrl MH, Wang JY. Dermatan Sulfate Is a Potential Master Regulator of IgH via Interactions with Pre-BCR, GTF2I, and BiP ER Complex in Pre-B Lymphoblasts [Preprint]. bioRxiv 2021; 12: 680212.
| Crossref | Google Scholar |
7 Wang JY, Zhang W, Rho J-h, Roehrl MW, Roehrl MH. A proteomic repertoire of autoantigens identified from the classic autoantibody clinical test substrate HEp-2 cells. Clin Proteomics 2020; 17: 35.
| Crossref | Google Scholar |
8 Zhang W, Rho J-h, Roehrl MH, Wang JY. A comprehensive autoantigen-ome of autoimmune liver diseases identified from dermatan sulfate affinity enrichment of liver tissue proteins. BMC Immunol 2019; 20(1): 21.
| Crossref | Google Scholar |
9 Zhang W, Rho J-h, Roehrl MW, Roehrl MH, Wang JY. A repertoire of 124 potential autoantigens for autoimmune kidney diseases identified by dermatan sulfate affinity enrichment of kidney tissue proteins. PLoS One 2019; 14(6): e0219018.
| Crossref | Google Scholar |
10 Consiglio CR, Cotugno N, Sardh F, Pou C, Amodio D, Rodriguez L, et al. The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19. Cell 2020; 183(4): 968-81.e7.
| Crossref | Google Scholar |
11 Gruber CN, Patel RS, Trachtman R, Lepow L, Amanat F, Krammer F, et al. Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C). Cell 2020; 183(4): 982-95.e14.
| Crossref | Google Scholar |
12 Gagiannis D, Steinestel J, Hackenbroch C, Schreiner B, Hannemann M, Bloch W, et al. Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD). Front Immunol 2020; 11: 587517.
| Crossref | Google Scholar |
13 Zhou Y, Han T, Chen J, Hou C, Hua L, He S, et al. Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID-19. Clin Transl Sci 2020; 13(6): 1077-86.
| Crossref | Google Scholar |
14 Fujii H, Tsuji T, Yuba T, Tanaka S, Suga Y, Matsuyama A, et al. High levels of anti-SSA/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review. Clin Rheumatol 2020; 39(11): 3171-5.
| Crossref | Google Scholar |
15 Sacchi MC, Tamiazzo S, Stobbione P, Agatea L, De Gaspari P, Stecca A, et al. SARS-CoV-2 infection as a trigger of autoimmune response. Clin Transl Sci 2021; 14: 898-907.
| Crossref | Google Scholar |
16 Franke C, Ferse C, Kreye J, Reincke SM, Sanchez-Sendin E, Rocco A, et al. High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms. Brain Behav Immun 2021; 93: 415-9.
| Crossref | Google Scholar |
17 Zuo Y, Yalavarthi S, Navaz S, Hoy C, Harbaugh A, Gockman K, et al. Autoantibodies stabilize neutrophil extracellular traps in COVID-19. JCI Insight 2021; 6(15): e150111.
| Crossref | Google Scholar | PubMed |
18 Chang SE, Feng A, Meng W, Apostolidis SA, Mack E, Artandi M, et al. New-Onset IgG Autoantibodies in Hospitalized Patients with COVID-19. Nat Commun 2021; 12(1): 5417.
| Crossref | Google Scholar | PubMed |
19 Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science (New York, NY) 2020; 370(6515): eabd4585.
| Crossref | Google Scholar |
20 Guilmot A, Maldonado Slootjes S, Sellimi A, Bronchain M, Hanseeuw B, Belkhir L, et al. Immune-mediated neurological syndromes in SARS-CoV-2-infected patients. J Neurol 2020; 268: 751-7.
| Crossref | Google Scholar |
21 Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 2019; 10(1): 1523.
| Crossref | Google Scholar |
22 Zhang JY, Wang XM, Xing X, Xu Z, Zhang C, Song JW, et al. Single-cell landscape of immunological responses in patients with COVID-19. Nat Immunol 2020; 21(9): 1107-18.
| Crossref | Google Scholar |
23 Davies JP, Almasy KM, McDonald EF, Plate L. Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies. ACS Infect Dis 2020; 6(12): 3174-89.
| Crossref | Google Scholar |
24 Klann K, Bojkova D, Tascher G, Ciesek S, Münch C, Cinatl J. Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Replication. Mol Cell 2020; 80(1): 164-74.e4.
| Crossref | Google Scholar |
25 Sun J, Ye F, Wu A, Yang R, Pan M, Sheng J, et al. Comparative Transcriptome Analysis Reveals the Intensive Early Stage Responses of Host Cells to SARS-CoV-2 Infection. Front Microbiol 2020; 11: 593857.
| Crossref | Google Scholar |
26 Bojkova D, Klann K, Koch B, Widera M, Krause D, Ciesek S, et al. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets. Nature 2020; 583(7816): 469-72.
| Crossref | Google Scholar |
27 Wilk AJ, Rustagi A, Zhao NQ, Roque J, Martínez-Colón GJ, McKechnie JL, et al. A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nat Med 2020; 26(7): 1070-6.
| Crossref | Google Scholar |
28 Lieberman NAP, Peddu V, Xie H, Shrestha L, Huang ML, Mears MC, et al. In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age. PLoS Biol 2020; 18(9): e3000849.
| Crossref | Google Scholar |
29 Riva L, Yuan S, Yin X, Martin-Sancho L, Matsunaga N, Pache L, et al. Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature 2020; 586(7827): 113-9.
| Crossref | Google Scholar |
30 Bouhaddou M, Memon D, Meyer B, White KM, Rezelj VV, Correa Marrero M, et al. The Global Phosphorylation Landscape of SARS-CoV-2 Infection. Cell 2020; 182(3): 685-712.e19.
| Crossref | Google Scholar |
31 Blanco-Melo D, Nilsson-Payant BE, Liu WC, Uhl S, Hoagland D, Møller R, et al. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19. Cell 2020; 181(5): 1036-45.e9.
| Crossref | Google Scholar |
32 Shen B, Yi X, Sun Y, Bi X, Du J, Zhang C, et al. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera. Cell 2020; 182(1): 59-72.e15.
| Crossref | Google Scholar |
33 Lamers MM, Beumer J, van der Vaart J, Knoops K, Puschhof J, Breugem TI, et al. SARS-CoV-2 productively infects human gut enterocytes. Science (New York, NY) 2020; 369(6499): 50-4.
| Crossref | Google Scholar |
34 Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 2020; 583(7816): 459-68.
| Crossref | Google Scholar |
35 Xiong Y, Liu Y, Cao L, Wang D, Guo M, Jiang A, et al. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. Emerg Microbes Infect 2020; 9(1): 761-70.
| Crossref | Google Scholar |
36 Vanderheiden A, Ralfs P, Chirkova T, Upadhyay AA, Zimmerman MG, Bedoya S, et al. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures. J Virol 2020; 94(19): e00985-20.
| Crossref | Google Scholar |
37 Appelberg S, Gupta S, Svensson Akusjärvi S, Ambikan AT, Mikaeloff F, Saccon E, et al. Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells. Emerg Microbes Infect 2020; 9(1): 1748-60.
| Crossref | Google Scholar |
38 Stukalov A, Girault V, Grass V, Bergant V, Karayel O, Urban C, et al. Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. Nature 2021; 594(7862): 246-252.
| Crossref | Google Scholar |
39 Wyler E, Mösbauer K, Franke V, Diag A, Gottula LT, Arsiè R, et al. Bulk and single-cell gene expression profiling of SARS-CoV-2 infected human cell lines identifies molecular targets for therapeutic intervention. iScience 2021; 24(3): 102151.
| Crossref | Google Scholar |
40 Liao M, Liu Y, Yuan J, Wen Y, Xu G, Zhao J, et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat Med 2020; 26(6): 842-4.
| Crossref | Google Scholar |
41 Laurent EMN, Sofianatos Y, Komarova A, Gimeno J-P, Tehrani PS, Kim D-K, et al. Global BioID-based SARS-CoV-2 proteins proximal interactome unveils novel ties between viral polypeptides and host factors involved in multiple COVID19-associated mechanisms [Preprint]. bioRxiv 2020; 2020.08.28.272955.
| Crossref | Google Scholar |
42 Li Y, Wang Y, Liu H, Sun W, Ding B, Zhao Y, et al. Urine proteome of COVID-19 patients. URINE (Amst) 2020; 2: 1-8.
| Crossref | Google Scholar |
43 Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 2019; 47(D1): D607-13.
| Crossref | Google Scholar |
44 Chatterjee D, Pieroni M, Fatah M, Charpentier F, Cunningham KS, Spears DA, et al. An autoantibody profile detects Brugada syndrome and identifies abnormally expressed myocardial proteins. Eur Heart J 2020; 41(30): 2878-90.
| Crossref | Google Scholar |
45 Vainio E, Lenoir GM, Franklin RM. Autoantibodies in three populations of Burkitt's lymphoma patients. Clin Exp Immunol 1983; 54(2): 387-96.
| Google Scholar |
46 Pandey S, Dioni I, Lambardi D, Real-Fernandez F, Peroni E, Pacini G, et al. Alpha actinin is specifically recognized by Multiple Sclerosis autoantibodies isolated using an N-glucosylated peptide epitope. Mol Cell Proteomics 2013; 12(2): 277-82.
| Crossref | Google Scholar |
47 Pott MC, Frede N, Wanders J, Hammarström L, Glocker EO, Glocker C, et al. Autoantibodies against BAFF, APRIL or IL21 - an alternative pathogenesis for antibody-deficiencies? BMC Immunol 2017; 18(1): 34.
| Crossref | Google Scholar |
48 Seko Y, Matsumoto A, Fukuda T, Imai Y, Fujimura T, Taka H, et al. A case of neonatal lupus erythematosus presenting delayed dilated cardiomyopathy with circulating autoantibody to annexin A6. Int Heart J 2007; 48(3): 407-15.
| Crossref | Google Scholar |
49 Creaney J, Dick IM, Yeoman D, Wong S, Robinson BWS. Auto-antibodies to β-F1-ATPase and vimentin in malignant mesothelioma. PLoS One 2011; 6(10): e26515.
| Crossref | Google Scholar |
50 Ikeda Y, Toda G, Hashimoto N, Maruyama T, Oka H. Antibody that recognizes conformations of calmodulin in the serum from patient with chronic active hepatitis. Biochem Biophys Res Commun 1987; 144(1): 191-7.
| Crossref | Google Scholar |
51 Boehm J, Orth T, Van Nguyen P, Söling H-D. Systemic lupus erythematosus is associated with increased auto-antibody titers against calreticulin and Grp94, but calreticulin is not the Ro/SS-A antigen. Eur J Clin Invest 1994; 24(4): 248-57.
| Crossref | Google Scholar |
52 Matsuo K, Xiang Y, Nakamura H, Masuko K, Yudoh K, Noyori K, et al. Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach. Arthritis Res Ther 2006; 8(6): R175.
| Crossref | Google Scholar |
53 Yokota S-i, Hirata D, Minota S, Higashiyama T, Kurimoto M, Yanagi H, et al. Autoantibodies against chaperonin CCT in human sera with rheumatic autoimmune diseases: comparison with antibodies against other Hsp60 family proteins. Cell Stress Chaperones 2000; 5(4): 337-46.
| Crossref | Google Scholar |
54 Hirai K, Maeda H, Omori K, Yamamoto T, Kokeguchi S, Takashiba S. Serum antibody response to group II chaperonin from Methanobrevibacter oralis and human chaperonin CCT. Pathog Dis 2013; 68(1): 12-9.
| Crossref | Google Scholar |
55 Pagaza-Straffon C, Marchat LA, Herrera L, Díaz-Chávez J, Avante MG, Rodríguez YP, et al. Evaluation of a panel of tumor-associated antigens in breast cancer. Cancer Biomark 2020; 27(2): 207-11.
| Crossref | Google Scholar |
56 Heo CK, Woo MK, Yu DY, Lee JY, Yoo JS, Yoo HS, et al. Identification of autoantibody against fatty acid synthase in hepatocellular carcinoma mouse model and its application to diagnosis of HCC. Int J Oncol 2010; 36(6): 1453-9.
| Crossref | Google Scholar |
57 Rosenberg AM, Cordeiro DM. Relationship between sex and antibodies to high mobility group proteins 1 and 2 in juvenile idiopathic arthritis. J Rheumatol 2000; 27(10): 2489-93.
| Google Scholar |
58 Stemmer C, Tuaillon N, Prieur AM, Muller S. Mapping of B-cell epitopes recognized by antibodies to histones in subsets of juvenile chronic arthritis. Clin Immunol Immunopathol 1995; 76(1): 82-9.
| Crossref | Google Scholar |
59 Wesierska-Gadek J, Penner E, Lindner H, Hitchman E, Sauermann G. Autoantibodies against different histone H1 subtypes in systemic lupus erythematosus sera. Arthritis Rheum 1990; 33(8): 1273-8.
| Crossref | Google Scholar |
60 Kwon YS, Chung J, Shin GT, Lee SY, Jang YJ. Variable region genes of human monoclonal autoantibodies to histones H2A and H2B from a systemic lupus erythematosus patient. Mol Immunol 2005; 42(3): 311-7.
| Crossref | Google Scholar |
61 Dieker J, Berden JH, Bakker M, Briand JP, Muller S, Voll R, et al. Autoantibodies against Modified Histone Peptides in SLE Patients Are Associated with Disease Activity and Lupus Nephritis. PLoS One 2016; 11(10): e0165373.
| Crossref | Google Scholar |
62 Ricotti GCBA, Bestagno M, Cerino A, Negri C, Caporali R, Cobianchi F, et al. Antibodies to hnRNP core protein A1 in connective tissue diseases. J Cell Biochem 1989; 40(1): 43-7.
| Crossref | Google Scholar |
63 Vencovský J, Kafková J, Staněk D, Raška I. Heterogenous nuclear RNP C1 and C2 core proteins are targets for an autoantibody found in the serum of a patient with systemic sclerosis and psoriatic arthritis. Arthritis Rheum 1997; 40(12): 2172-7.
| Crossref | Google Scholar |
64 Zhang J-Y, Chan EKL, Peng X-X, Tan EM. A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma. J Exp Med 1999; 189(7): 1101-10.
| Crossref | Google Scholar |
65 Britton S, Froment C, Frit P, Monsarrat B, Salles B, Calsou P. Cell nonhomologous end joining capacity controls SAF-A phosphorylation by DNA-PK in response to DNA double-strand breaks inducers. Cell Cycle 2009; 8(22): 3717-22.
| Crossref | Google Scholar |
66 Harlow L, Rosas IO, Gochuico BR, Mikuls TR, Dellaripa PF, Oddis CV, et al. Identification of citrullinated hsp90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease. Arthritis Rheum 2013; 65(4): 869-79.
| Crossref | Google Scholar |
67 Pashov A, Kenderov A, Kyurkchiev S, Kehayov I, Hristova S, Lacroix-Desmazes S, et al. Autoantibodies to heat shock protein 90 in the human natural antibody repertoire. Int Immunol 2002; 14(5): 453-61.
| Crossref | Google Scholar |
68 Qin HY, Mahon JL, Atkinson MA, Chaturvedi P, Lee-Chan E, Singh B. Type 1 diabetes alters anti-hsp90 autoantibody isotype. J Autoimmun 2003; 20(3): 237-45.
| Crossref | Google Scholar |
69 Tishler M, Shoenfeld Y. Anti-heat-shock protein antibodies in rheumatic and autoimmune diseases. Semin Arthritis Rheum 1996; 26(2): 558-63.
| Crossref | Google Scholar |
70 Bläß S, Union A, Raymackers J, Schumann F, Ungethüm U, Müller-Steinbach S, et al. The stress protein BiP is overexpressed and is a major B and T cell target in rheumatoid arthritis. Arthritis Rheum 2001; 44(4): 761-71.
| Crossref | Google Scholar |
71 Horváth L, Cervenak L, Oroszlán M, Prohászka Z, Uray K, Hudecz F, et al. Antibodies against different epitopes of heat-shock protein 60 in children with type 1 diabetes mellitus. Immunol Lett 2002; 80(3): 155-62.
| Crossref | Google Scholar |
72 Minohara M. [Heat shock protein 105 in multiple sclerosis]. Nihon Rinsho 2003; 61(8): 1317-22.
| Google Scholar |
73 Kobayashi T, Yura T, Yanagi H. The increment of anti-ORP150 autoantibody in initial stages of atheroma in high-fat diet fed mice. J Vet Med Sci 2002; 64(2): 177-80.
| Crossref | Google Scholar |
74 Ola TO, Biro PA, Hawa MI, Ludvigsson J, Locatelli M, Puglisi MA, et al. Importin beta: a novel autoantigen in human autoimmunity identified by screening random peptide libraries on phage. J Autoimmun 2006; 26(3): 197-207.
| Crossref | Google Scholar |
75 Ueda K, Nakanishi T, Shimizu A, Takubo T, Matsuura N. Identification of L-plastin autoantibody in plasma of patients with non-Hodgkin's lymphoma using a proteomics-based analysis. Ann Clin Biochem 2008; 45(1): 65-9.
| Crossref | Google Scholar |
76 Senécal J-L, Rauch J, Grodzicky T, Raynauld J-P, Uthman I, Nava A, et al. Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus. Arthritis Rheum 1999; 42(7): 1347-53.
| Google Scholar |
77 Frampton G, Moriya S, Pearson JD, Isenberg DA, Ward FJ, Smith TA, et al. Identification of candidate endothelial cell autoantigens in systemic lupus erythematosus using a molecular cloning strategy: a role for ribosomal P protein P0 as an endothelial cell autoantigen. Rheumatology (Oxford, England) 2000; 39(10): 1114-20.
| Crossref | Google Scholar |
78 Bledzhyants DA, Muratov RM, Movsesyan RR, Podlubnaya ZA. Autoantibodies to myosin light chains in the blood as early marker of myocardial injury after aortocoronary bypass surgery. Bull Exp Biol Med 2007; 144(2): 241-5.
| Crossref | Google Scholar |
79 Batova IN, Richardson RT, Widgren EE, O'Rand MG. Analysis of the autoimmune epitopes on human testicular NASP using recombinant and synthetic peptides. Clin Exp Immunol 2000; 121(2): 201-9.
| Crossref | Google Scholar |
80 Qin Z, Lavingia B, Zou Y, Stastny P. Antibodies against nucleolin in recipients of organ transplants. Transplantation 2011; 92(7): 829-35.
| Crossref | Google Scholar |
81 Ulanet DB, Torbenson M, Dang CV, Casciola-Rosen L, Rosen A. Unique conformation of cancer autoantigen B23 in hepatoma: a mechanism for specificity in the autoimmune response. Proc Natl Acad Sci U S A 2003; 100(21): 12361-6.
| Crossref | Google Scholar |
82 Nagayama S, Yokoi T, Tanaka H, Kawaguchi Y, Shirasaka T, Kamataki T. Occurrence of autoantibody to protein disulfide isomerase in patients with hepatic disorder. J Toxicol Sci 1994; 19(3): 163-9.
| Crossref | Google Scholar |
83 Takasaki Y, Kaneda K, Matsushita M, Yamada H, Nawata M, Matsudaira R, et al. Glyceraldehyde 3-phosphate dehydrogenase is a novel autoantigen leading autoimmune responses to proliferating cell nuclear antigen multiprotein complexes in lupus patients. Int Immunol 2004; 16(9): 1295-304.
| Crossref | Google Scholar |
84 Gut J, Christen U, Frey N, Koch V, Stoffler D. Molecular mimicry in halothane hepatitis: biochemical and structural characterization of lipoylated autoantigens. Toxicology 1995; 97(1–3): 199-224.
| Crossref | Google Scholar |
85 Mojtahedi Z, Safaei A, Yousefi Z, Ghaderi A. Immunoproteomics of HER2-positive and HER2-negative breast cancer patients with positive lymph nodes. OMICS 2011; 15(6): 409-18.
| Crossref | Google Scholar |
86 Mayo I, Arribas J, Villoslada P, Alvarez DoForno R, Rodriguez-Vilarino S, Montalban X, et al. The proteasome is a major autoantigen in multiple sclerosis. Brain 2002; 125(12): 2658-67.
| Crossref | Google Scholar |
87 Feist E, Kuckelkorn U, Dörner T, Dönitz H, Scheffler S, Hiepe F, et al. Autoantibodies in primary Sjögren’s syndrome are directed against proteasomal subunits of the α and β type. Arthritis Rheum 1999; 42(4): 697-702.
| Crossref | Google Scholar |
88 Bohring C, Krause W. Characterization of spermatozoa surface antigens by antisperm antibodies and its influence on acrosomal exocytosis. Am J Reprod Immunol 2003; 50(5): 411-9.
| Crossref | Google Scholar |
89 Sugimoto K, Hiwasa T, Shibuya K, Hirano S, Beppu M, Isose S, et al. Novel autoantibodies against the proteasome subunit PSMA7 in amyotrophic lateral sclerosis. J Neuroimmunol 2018; 325: 54-60.
| Crossref | Google Scholar |
90 Roessler M, Rollinger W, Mantovani-Endl L, Hagmann ML, Palme S, Berndt P, et al. Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis. Mol Cell Proteomics 2006; 5(11): 2092-101.
| Crossref | Google Scholar |
91 Vlachoyiannopoulos PG, Frillingos S, Tzioufas AG, Seferiadis K, Moutsopoulos HM, Tsolas O. Circulating antibodies to prothymosin α in systemic lupus erythematosus. Clin Immunol Immunopathol 1989; 53(2): 151-60.
| Crossref | Google Scholar |
92 Yamasaki Y, Narain S, Hernandez L, Barker T, Ikeda K, Segal MS, et al. Autoantibodies against the replication protein A complex in systemic lupus erythematosus and other autoimmune diseases. Arthritis Res Ther 2006; 8(4): R111.
| Crossref | Google Scholar |
93 Luna Coronell JA, Sergelen K, Hofer P, Gyurján I, Brezina S, Hettegger P, et al. The Immunome of Colon Cancer: Functional In Silico Analysis of Antigenic Proteins Deduced from IgG Microarray Profiling. Genom Proteom Bioinform 2018; 16(1): 73-84.
| Crossref | Google Scholar |
94 Guialis A, Patrinou-Georgoula M, Tsifetaki N, Aidinis V, Sekeris CE, Molitsopouios HM. Anti-5S RNA/protein (RNP) antibody levels correlate with disease activity in a patient with systemic lupus erythematosus (SLE) nephritis. Clin Exp Immunol 1994; 95(3): 385-9.
| Crossref | Google Scholar |
95 Gerli R, Caponi L. Anti-ribosomal P protein antibodies. Autoimmunity 2005; 38(1): 85-92.
| Crossref | Google Scholar |
96 Elkon K, Bonfa E, Llovet R, Danho W, Weissbach H, Brot N. Properties of the ribosomal P2 protein autoantigen are similar to those of foreign protein antigens. Proc Natl Acad Sci U S A 1988; 85(14): 5186-9.
| Crossref | Google Scholar |
97 Chai Z, Sarcevic B, Mawson A, Toh BH. SET-related cell division autoantigen-1 (CDA1) arrests cell growth. J Biol Chem 2001; 276(36): 33665-74.
| Crossref | Google Scholar |
98 Hof D, Cheung K, de Rooij DJ, van den Hoogen FH, Pruijn GJ, van Venrooij WJ, et al. Autoantibodies specific for apoptotic U1-70K are superior serological markers for mixed connective tissue disease. Arthritis Res Ther 2005; 7(2): R302-9.
| Crossref | Google Scholar |
99 McClain MT, Ramsland PA, Kaufman KM, James JA. Anti-sm autoantibodies in systemic lupus target highly basic surface structures of complexed spliceosomal autoantigens. J Immunol (Baltimore, MD: 1950) 2002; 168(4): 2054-62.
| Crossref | Google Scholar |
100 Brahms H, Raymackers J, Union A, de Keyser F, Meheus L, Lührmann R. The C-terminal RG dipeptide repeats of the spliceosomal Sm proteins D1 and D3 contain symmetrical dimethylarginines, which form a major B-cell epitope for anti-Sm autoantibodies. J Biol Chem 2000; 275(22): 17122-9.
| Crossref | Google Scholar |
101 Iizuka N, Okamoto K, Matsushita R, Kimura M, Nagai K, Arito M, et al. Identification of autoantigens specific for systemic lupus erythematosus with central nervous system involvement. Lupus 2010; 19(6): 717-26.
| Crossref | Google Scholar |
102 Overzet K, Gensler TJ, Kim SJ, Geiger ME, van Venrooij WJ, Pollard KM, et al. Small nucleolar RNP scleroderma autoantigens associate with phosphorylated serine/arginine splicing factors during apoptosis. Arthritis Rheum 2000; 43(6): 1327-36.
| Crossref | Google Scholar |
103 Gordon P, Khamashta MA, Rosenthal E, Simpson JM, Sharland G, Brucato A, et al. Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupus. J Rheumatol 2004; 31(12): 2480-7.
| Google Scholar |
104 Cortini A, Bembich S, Marson L, Cocco E, Edomi P. Identification of novel non-myelin biomarkers in multiple sclerosis using an improved phage-display approach. PLoS One 2019; 14(12): e0226162.
| Crossref | Google Scholar |
105 Geng X, Biancone L, Dai HH, Lin JJ-C, Yoshizaki N, Dasgupta A, et al. Tropomyosin isoforms in intestinal mucosa: production of autoantibodies to tropomyosin isoforms in ulcerative colitis. Gastroenterology 1998; 114(5): 912-22.
| Crossref | Google Scholar |
106 Mahesh SP, Li Z, Buggage R, Mor F, Cohen IR, Chew EY, et al. Alpha tropomyosin as a self-antigen in patients with Behçet’s disease. Clin Exp Immunol 2005; 140(2): 368-75.
| Crossref | Google Scholar |
107 Kimura A, Sakurai T, Yamada M, Koumura A, Hayashi Y, Tanaka Y, et al. Anti-endothelial cell antibodies in patients with cerebral small vessel disease. Curr Neurovasc Res 2012; 9(4): 296-301.
| Crossref | Google Scholar |
108 Zhao X, Cheng Y, Gan Y, Jia R, Zhu L, Sun X. Anti-tubulin-α-1C autoantibody in systemic lupus erythematosus: a novel indicator of disease activity and vasculitis manifestations. Clin Rheumatol 2018; 37(5): 1229-37.
| Crossref | Google Scholar |
109 Kimura A, Yoshikura N, Koumura A, Hayashi Y, Kobayashi Y, Kobayashi I, et al. Identification of target antigens of naturally occurring autoantibodies in cerebrospinal fluid. J Proteomics 2015; 128: 450-7.
| Crossref | Google Scholar |
110 Betteridge ZE, Gunawardena H, Chinoy H, North J, Ollier WER, Cooper RG, et al. Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis. Ann Rheum Dis 2009; 68(10): 1621-5.
| Crossref | Google Scholar |
111 Miyachi K, Hosaka H, Nakamura N, Miyakawa H, Mimori T, Shibata M, et al. Anti-p97/VCP antibodies: an autoantibody marker for a subset of primary biliary cirrhosis patients with milder disease? Scand J Immunol 2006; 63(5): 376-82.
| Crossref | Google Scholar |
112 Bang H, Egerer K, Gauliard A, Lüthke K, Rudolph PE, Fredenhagen G, et al. Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Arthritis Rheum 2007; 56(8): 2503-11.
| Crossref | Google Scholar |
113 Mao J, Ladd J, Gad E, Rastetter L, Johnson MM, Marzbani E, et al. Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer. J Transl Med 2014; 12: 121.
| Crossref | Google Scholar |
114 Wen J, Yaneva M. Mapping of epitopes on the 86 kDa subunit of the Ku autoantigen. Mol Immunol 1990; 27(10): 973-80.
| Crossref | Google Scholar |
115 Hoa S, Hudson M, Troyanov Y, Proudman S, Walker J, Stevens W, et al. Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations. Medicine (Baltimore) 2016; 95(35): e4713.
| Crossref | Google Scholar |
116 Kistner A, Bigler MB, Glatz K, Egli SB, Baldin FS, Marquardsen FA, et al. Characteristics of autoantibodies targeting 14-3-3 proteins and their association with clinical features in newly diagnosed giant cell arteritis. Rheumatology (Oxford, England) 2017; 56(5): 829-34.
| Crossref | Google Scholar |
117 van Beers-Tas MH, Marotta A, Boers M, Maksymowych WP, van Schaardenburg D. A prospective cohort study of 14-3-3η in ACPA and/or RF-positive patients with arthralgia. Arthritis Res Ther 2016; 18: 76.
| Crossref | Google Scholar |
118 Qiu J, Choi G, Li L, Wang H, Pitteri SJ, Pereira-Faca SR, et al. Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera. J Clin Oncol 2008; 26(31): 5060-6.
| Crossref | Google Scholar |
119 Chakravarti R, Gupta K, Swain M, Willard B, Scholtz J, Svensson LG, et al. 14-3-3 in Thoracic Aortic Aneurysms: Identification of a Novel Autoantigen in Large Vessel Vasculitis. Arthritis Rheumatol (Hoboken, NJ) 2015; 67(7): 1913-21.
| Crossref | Google Scholar |
120 Imai H, Chan EK, Kiyosawa K, Fu XD, Tan EM. Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma. J Clin Invest 1993; 92(5): 2419-26.
| Crossref | Google Scholar |
121 Beutgen VM, Schmelter C, Pfeiffer N, Grus FH. Autoantigens in the trabecular meshwork and glaucoma-specific alterations in the natural autoantibody repertoire. Clin Transl Immunol 2020; 9(3): e01101.
| Crossref | Google Scholar |
122 Becker A, Ludwig N, Keller A, Tackenberg B, Eienbröker C, Oertel WH, et al. Myasthenia gravis: analysis of serum autoantibody reactivities to 1827 potential human autoantigens by protein macroarrays. PLoS One 2013; 8(3): e58095.
| Crossref | Google Scholar |
123 Alexopoulos H, Magira E, Bitzogli K, Kafasi N, Vlachoyiannopoulos P, Tzioufas A, et al. Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: studies in 8 stuporous and comatose patients. Neurol Neuroimmunol Neuroinflamm 2020; 7(6): e893.
| Crossref | Google Scholar |
124 Wabnitz G, Balta E, Samstag Y. L-plastin regulates the stability of the immune synapse of naive and effector T-cells. Adv Biol Regul 2017; 63: 107-14.
| Crossref | Google Scholar |
125 Mossabeb R, Seiberler S, Mittermann I, Natter S, Kraft D, Valenta R, et al. Characterization of a novel isoform of α-nascent polypeptide-associated complex as IgE-defined autoantigen. J Invest Dermatol 2002; 119(4): 820-9.
| Crossref | Google Scholar |
